By EIV Diagnostics · October 21, 2026
Gabapentin Drug Test: What Shows Up and What Doesn't
Does gabapentin show up on a drug test? Learn which panels miss it, how labs test for it, how long it stays in urine, and how to order a test in Fresno.

Gabapentin does not show up on a standard workplace or urine drug screen. Those panels are built around a short list of drug categories, and gabapentin is not on it. It can be detected, though, if someone orders a test that targets it by name. That test is usually a lab-based urine assay that reports a concentration, not a simple yes or no.
This guide covers what a routine screen checks, when gabapentin gets tested on purpose, how long it stays detectable, and why a positive result needs context. It also covers how to get a gabapentin test done in the Fresno area.
TL;DR
- Standard 5-panel and 10-panel screens do not include gabapentin. A test for it has to be requested specifically.
- In people with healthy kidneys, gabapentin clears in roughly two days. Kidney function changes that timeline a lot.
- Clinical gabapentin testing is usually quantitative and lab-run. Instant dip strips are presumptive only and need lab confirmation.
- A positive result shows the drug is present. It does not show misuse, and it should not be the sole basis for a treatment or job decision.
- If you take gabapentin as prescribed, tell the person ordering your test, and bring your dose and prescriber’s name.
Table of Contents
- Does gabapentin show up on a standard drug test?
- Why it gets missed: it isn’t a federally controlled drug
- How labs actually test for gabapentin
- How long gabapentin stays detectable
- What a positive result does and doesn’t mean
- Instant and at-home gabapentin tests: what to trust
- Our perspective: a test is a data point, not a verdict
- Getting a gabapentin test in Fresno and the Central Valley
- Before your test: a short checklist
- FAQ
- Sources
Does gabapentin show up on a standard drug test?
No, not on the panels most people encounter. Federal workplace testing is governed by SAMHSA, and the federal panel is limited to categories such as marijuana, cocaine, opioids, amphetamines and PCP. Gabapentin is not among them. The rapid cups and dipcards used by many employers, clinics and probation programs follow the same logic: they screen for those categories and nothing else.
There is one exception to keep in mind. Employers outside the federal program can add substances to their own testing, for example after an accident or on reasonable suspicion. If that happens, the lab has to be told to look for gabapentin, because it will not turn up by default.
In practice, here is how common test types treat it:
| Test type | Usually includes gabapentin? | What to know |
|---|---|---|
| 5-panel or 10-panel urine screen | No | Built for the federal drug categories |
| Standard hospital urine drug screen | Rarely | A 2021 clinical and forensic review is not the source here; see the note below |
| Gabapentin-specific urine assay | Yes | Ordered by name, usually quantitative |
| Expanded toxicology or drug monitoring panel | Sometimes | Depends on what the provider selects |
| Instant gabapentin dip strip | Yes, presumptively | Not a clinical result, needs lab confirmation |
Note on the hospital row: reviews of clinical practice describe gabapentin as not frequently included in standard hospital screens, so assume it is absent unless it was ordered.
Why it gets missed: it isn’t a federally controlled drug
Gabapentin is not a federally scheduled controlled substance. According to Drugs.com, a handful of states classify it as Schedule V, and several others require its prescriptions to be reported to the state monitoring program. The same page lists the states that schedule it, and California is not among them. Because it is not federally scheduled, it has not been built into the default drug-of-abuse panels.
That does not mean it is risk-free. Research on people with substance use disorders found that gabapentinoid abuse has been rising, and that gabapentin was positive in about 5.3% of suspected substance use cases in one major study. The authors point out that many routine screens miss it even when misuse is suspected. Many clinicians now add it to the toxicology panel whenever a patient is prescribed it.
The same gap shows up elsewhere in toxicology. Newer adulterants in the illicit supply, such as the sedative medetomidine that the CDC has warned about, are also not covered by routine panels. A summary of the CDC warning on medetomidine in illegal fentanyl shows why expanded testing, chosen deliberately, matters when standard screens come back negative but the clinical picture says otherwise.

How labs actually test for gabapentin
A lab test for gabapentin is built differently from a cup test.
Quantitative assays
Clinical monitoring is usually quantitative. Instead of positive or negative, the report gives a concentration. The FDA clearance summary for one widely used enzyme immunoassay, the ARK Gabapentin Assay, describes a measuring range of about 0.75 to 40 µg/mL. A number is far more useful than a yes or no. Gabapentin is used at very different doses, and the right interpretation depends on the dose, the timing of the last pill and kidney function.
Confirmation by mass spectrometry
The other common approach is liquid chromatography with tandem mass spectrometry (LC-MS/MS), which identifies and measures the molecule directly. It is the usual way to confirm a presumptive result. The FDA’s guidance on drugs of abuse tests notes that preliminary positive results from rapid tests need laboratory confirmation by a method such as GC/MS or LC/MS.
A quirk that matters for interpretation
Because gabapentin leaves the body almost entirely unchanged in urine, concentrations can be extremely high. A published laboratory study found that at urine levels above 1 mg/mL, gabapentin can create an amphetamine-like interference in one mass spectrometry method through in-source fragmentation. That is a reason to run confirmation in a lab that knows the method’s limits, and to give the lab your full medication list. It is not a reason to worry about a standard cup screen.
How long gabapentin stays detectable
There is no single number, because gabapentin is cleared by the kidneys. Per StatPearls, the half-life in people with normal kidney function is about 5 to 7 hours, and it typically takes around two days for the body to clear the drug. Specialized urine testing is generally described as detecting it for about 24 to 48 hours after the last dose, as one clinician-reviewed guide puts it. Your result will depend on several things:
- Kidney function. A pharmacokinetic study across different degrees of renal function found that reduced function slows elimination considerably. Lower kidney function means a longer window and higher concentrations.
- Dose and timing. Higher doses and recent doses give higher urine levels. Absorption is not proportional to dose, so doubling the dose does not double what a test shows.
- Hydration and urine concentration. Very dilute or very concentrated samples shift the numbers.
- Specimen type. Urine is the most common. Blood gives a shorter, more recent picture.
This non-linear absorption is also why a urine level is a poor tool for checking exactly how many milligrams someone took. It can tell a provider whether the drug is present and roughly in the expected range. It cannot reliably prove a specific dose.
What a positive result does and doesn’t mean
A positive gabapentin result means the drug was in the sample. That is all. The FDA states in its guidance on home-use drug tests that a positive test only shows presence, and the line between prescribed use and misuse takes a clinical evaluation of dose, frequency and medical need.
Two situations come up often:
- You have a prescription. A positive result is expected and normal. Bring the prescription details, and if a job or program requires testing, give the information to the medical review officer or the ordering clinician before the test, not after.
- You don’t have a prescription and the result is positive. Do not guess at the cause or argue the lab. Ask the ordering provider for the quantitative result and the confirmation method, and talk with your own physician. Anyone worried about their use can ask a doctor for help without it being a punishment. Gabapentin is increasingly used as a non-opioid option for chronic pain, so routine monitoring is often about safety and adherence.
Gabapentin also does not read as a benzodiazepine on a properly run test. Confusion usually comes from other issues: sedation effects feel similar to some people, and the drug is sometimes bundled into the same monitoring panels as benzodiazepines and opioids. A confirmed lab result separates them.
Instant and at-home gabapentin tests: what to trust
Gabapentin dip strips are sold online. Before you buy one, know their limits:
- They are presumptive. The FDA says preliminary positives from rapid tests need confirmation by a laboratory.
- Many are labeled for forensic or non-clinical use, not for medical decisions.
- Handling, timing and other substances in the sample can throw off the reading.
- A strip gives no concentration, so it says nothing about whether your level is therapeutic.
If the result will affect your treatment, job, custody case or probation, a laboratory test with documented specimen handling is the version that counts.
Our perspective: a test is a data point, not a verdict
We run a pathology laboratory, and in our experience the biggest problem with drug testing is not the technology but the way results are read. A drug screen that does not list gabapentin cannot clear a patient of anything, and a positive gabapentin level cannot, by itself, convict anyone of anything.

We think gabapentin testing belongs in the same category as any other therapeutic monitoring. When a clinician orders it because a patient is prescribed the drug, the goal is to confirm the medication is being taken safely and at an effective level. That is a supportive use, and it changes the tone of the conversation from suspicion to care.
For that to work, three things need to be true. The test has to be the right one: quantitative, confirmed by a reliable method, and interpreted alongside kidney function. The report has to reach the ordering provider quickly. And the patient has to be able to get the draw without taking a half day off work. That last piece is why we offer mobile phlebotomy across the Central Valley.
— EIV Diagnostics
Getting a gabapentin test in Fresno and the Central Valley
The route depends on who you are:
- You are a patient and your doctor ordered it. Take the order to the lab. Our clinical pathology team works with provider orders, and our board-certified pathologists review the work.
- You want a test without a doctor’s visit. We take self-pay customers. See our self-pay testing page for how it works and which tests are available. Ask whether the specific gabapentin assay you need is offered before you book, since test menus change.
- You are a provider. You can send specimens for toxicology and clinical pathology work. Our services page lists what we offer, including toxicology and pharmacogenomic testing.
- You can’t easily get to a lab. Our mobile phlebotomy service comes to your home or office, from $65 per visit as a one-off charge.
We serve Fresno, Clovis, Madera, Sanger, Reedley, Kerman, Visalia, Tulare, Hanford, Kingsburg, Lemoore and the surrounding counties.
If your provider is also considering how you metabolize medications in general, our article on CYP2C19 genotyping explains how pharmacogenomic testing works. It does not apply to gabapentin specifically, because gabapentin is cleared by the kidneys instead of liver enzymes, but it is relevant if you take other medications.
Before your test: a short checklist
- Confirm exactly what is being tested. Ask whether gabapentin is on the panel, and whether the result will be quantitative.
- List every medication and supplement you take, with doses. Include over-the-counter products.
- Note your last dose and when you took it.
- Mention any kidney problems. They change how your result should be read.
- Keep a copy of your prescription and the prescriber’s contact information.
- Ask how a positive result will be confirmed and who receives it.
If you have questions about a result you already received, the person to see is the provider who ordered the test. If you think your results are affecting your care unfairly, ask for a review by a medical professional, such as your physician or the employer’s medical review officer. If you are worried about your own use of gabapentin, a primary care doctor can help without judgment.
FAQ
Will gabapentin make me fail a drug test?
Not on a standard 5-panel or 10-panel screen, because gabapentin is not part of the federal testing panel. It can be detected only if the test specifically includes it. If you have a prescription, tell the ordering party in advance.
How long does gabapentin show up in urine?
In people with normal kidney function, the body clears gabapentin in about two days, so a targeted urine test generally detects it for roughly 24 to 48 hours after the last dose. People with reduced kidney function may test positive longer. Your prescriber can tell you what applies to you.
Does gabapentin show up as a benzo or an amphetamine?
It should not. On a correctly run test it is its own analyte. In rare cases, very high gabapentin levels have caused an amphetamine-like interference in one mass spectrometry method, which is why unexpected positives should be confirmed by a laboratory using a second method.
Can I buy a gabapentin test and use it at home?
You can buy dip strips, but their results are presumptive and many are not intended for medical use. Anything that will affect treatment, work or legal matters should be confirmed by a laboratory. A lab can also report a concentration, which a strip cannot.
Sources
- SAMHSA: Workplace Drug Testing Resources
- Drugs.com: Is gabapentin a controlled substance?
- Abuse of gabapentinoids in individuals with substance use disorders
- FDA 510(k) summary: ARK Gabapentin Assay
- FDA: Drugs of Abuse Tests
- FDA: Drugs of Abuse Home Use Test
- Characterization of an Amphetamine Interference from Gabapentin in an LC-HRMS Method
- StatPearls: Gabapentin
- Pharmacokinetics of gabapentin in subjects with various degrees of renal function
- Doctronic: Does Gabapentin Show Up on a Drug Test?